Abstract |
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit the growth of various cancers by mechanism(s) that include the suppression of the insulin-like growth factors ( IGF)-I and/or -II. In this study, nude mice bearing orthotopic implants of MDA-MB-435 human estrogen-independent breast carcinoma received 39 days of therapy with GH-RH antagonist JV-1-36 (20 microg/day). The treatment significantly inhibited tumor growth by 71.1% (p<0.01) and nullified the metastatic potential of MDA-MB-435 cells. Four of eight control mice (50%) developed metastases in the lymph nodes and one (12.5%) in the lung, but none of the animals receiving JV-1-36 showed metastatic spread. GH-RH antagonist JV-1-36 inhibited the growth of MDA-MB-435 cells in vitro, while IGF-I stimulated it. However, mRNA for IGF-I or -II was not detected in MDA-MB-435 cells, indicating that the suppression of autocrine IGFs may not be involved in the antiproliferative mechanism. Using ligand competition assays with (125)I-labeled GH-RH antagonist JV-1-42, specific high-affinity binding sites for GH-RH were found on tumor membranes. Reverse transcription-polymerase chain reaction revealed the expression of mRNA for GH-RH receptor splice variant-1 in MDA-MB-435 tumors. Our results suggest that the antitumorigenic action of GH-RH antagonists on MDA-MB-435 breast cancer could be direct and mediated by tumoral GH-RH receptors.
|
Authors | I Chatzistamou, A V Schally, J L Varga, K Groot, R Busto, P Armatis, G Halmos |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 12
Issue 9
Pg. 761-8
(Oct 2001)
ISSN: 0959-4973 [Print] England |
PMID | 11593058
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- JV 1-36
- RNA, Messenger
- Receptors, Growth Factor
- Insulin-Like Growth Factor I
- Insulin-Like Growth Factor II
- Growth Hormone-Releasing Hormone
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Breast Neoplasms
(drug therapy, metabolism, pathology)
- Cell Division
(drug effects)
- Female
- Growth Hormone-Releasing Hormone
(analogs & derivatives, antagonists & inhibitors, metabolism, pharmacology)
- Humans
- Insulin-Like Growth Factor I
(metabolism)
- Insulin-Like Growth Factor II
(metabolism)
- Mice
- Mice, Nude
- Neoplasm Metastasis
- RNA, Messenger
(analysis)
- Receptors, Growth Factor
(metabolism)
- Reverse Transcriptase Polymerase Chain Reaction
- Tumor Cells, Cultured
- Xenograft Model Antitumor Assays
|